NASDAQ: HKPDHong Kong Pharma Digital Technology Holdings Ltd Stock
$1.35-0.01 (-0.74%)
Updated Sep 12, 2025
HKPD Price
$1.35
Fair Value Price
N/A
Market Cap
$14.85M
52 Week Low
$0.81
52 Week High
$3.79
P/E
-450x
P/B
2.98x
P/S
0.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$20.31M
Earnings
-$27.06k
Gross Margin
11.9%
Operating Margin
0.66%
Profit Margin
-0.1%
Debt to Equity
0.89
Operating Cash Flow
$569k
Beta
1.36
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HKPD Overview
Hong Kong Pharma Digital Technology Holdings Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. It focuses on cross-border pharmaceutical warehousing, cross-border OTC registration and import, and OTC product wholesale services. The company was founded by Lap Sun Wong on August 17, 2023 and is headquartered in Hong Kong.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HKPD's potential to beat the market
- HKPD doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Leisure
Industry Rating
D
HKPD
RankedUnranked of 28
RankedUnranked of 28
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $40.67 | B | |
| $78.38 | B | |
| $8.92 | B |
Be the first to know about important HKPD news, forecast changes, insider trades & much more!
HKPD News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HKPD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HKPD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HKPD is good value based on its book value relative to its share price (2.98x), compared to the US Leisure industry average (4.51x)
P/B vs Industry Valuation
HKPD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HKPD due diligence checks available for Premium users.
Valuation
HKPD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-450x
Industry
30.86x
Market
36.96x
HKPD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.98x
Industry
4.51x
HKPD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HKPD's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
HKPD's Earnings (EBIT) of $133.78k... subscribe to Premium to read more.
Interest Coverage Financials
HKPD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.4M
Liabilities
$4.4M
Debt to equity
0.89
HKPD's short-term assets ($8.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HKPD's short-term assets ($8.73M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HKPD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
HKPD's operating cash flow ($569.21k)... subscribe to Premium to read more.
Debt Coverage Financials
HKPD vs Leisure Stocks
Hong Kong Pharma Digital Technology Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.